|
In this issue:
|
|
|
|
|
Artificial intelligence predicts recurrence years ahead
New research shows value of machine learning in heading off prostate cancer
|
|
|
|
|
Mental health toll of prostate cancer on partners
Results from Europa Uomo’s EU-ProPER study show effect on emotional and social life
|
|
|
|
|
Making patient advocates into experts
Europa Uomo holding ‘summer school’ to train member organisation representatives
|
|
|
|
|
I want to ensure no-one else endures what I am facing
Europa Uomo Board member Marko Koivuneva has experienced radiation-induced cystitis ever since treatment for prostate cancer. Here, he talks of his regret at some of the decisions made that led to this complication.
|
|
|
Prostate Research and Treatments
Duration of ADT in prostate cancer patients receiving postoperative radiotherapy
A paper in The Lancet reports on the RADICALS-HD randomised controlled trial comparing long-course and short-course androgen deprivation therapy (ADT) in prostate cancer patients receiving postoperative radiotherapy.
Adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For patients who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy, says the study.
|
|
|
Progress of PRAISE-U
European Urology Today has reported on a meeting of representatives of various European national urological societies in June 2024, where Hein Van Poppel of the European Association of Urology described progress made by PRAISE-U (PRostate cancer Awareness and Initiative for Screening in the European Union) project. You can read the article here.
|
|
|
Video interview on early detection of prostate cancer and the PRAISE-U project
Hein Van Poppel is interviewed by urologist Giancarlo Marra about prostate cancer early detection and the PRAISE-U project in a video for EAU’s educational platform UROONCO.
|
|
|
Your thoughts about AI and urology care?
Through our contacts in the USA, we have received the following request.
Peter Evancho, a second-year medical student at the University of Maryland School of Medicine, is conducting a short survey to examine the the integration of artificial intelligence (AI) into urologic practice and understand both its promise and the substantial ethical, legal, and regulatory challenges it poses.
More information here. The survey is completely anonymous and can be filled in until September 1st.
|
|
|
Europa Uomo News
First meeting of the new Board
On 9th August, the Europa Uomo Board and its new member Kees Vos will meet for the first time since the Annual General Meeting in Milan in May.
Important agenda points: the EU-PROPER study, the 2024 Summer School (27 participants), a new shared-decision making survey, the chatbot, new membership applications from Croatia and Bosnia-Herzegovina, ESMO Patient Advocates Working Group and forthcoming conferences (EMUC24, EAU25, General Assembly).
|
|
|
Items of Interest
Which MEPs from your country have an influence on health?
The European Patient Forum has mapped the Members of the European Parliament (MEPs) who will play an important role.
In the document, you can filter the data based on your country, and see which MEPs will play a role in the Committee on the Environment, Public Health and Food Safety (ENVI) and the Subcommittee on Public Health (SANT). Email addresses are also included.
|
|
|
|
|
|
FREE SUBSCRIPTION TO EUROPA UOMO MONTHLY UPDATE
All previous issues are available on website: www.europa-uomo.org/newsletters/
|
|
